Doruk Erkan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 33

Top Topics

Pulmonary Embolism

Systemic Lupus Erythematosus

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Turkish journal of haematology : official journal of Turkish Society of Haematology

Annals of the rheumatic diseases

Nature reviews. Rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Doruk Erkan
Antiphospholipid Syndrome: To Classify or Not to Classify? Turkish journal of haematology : official journal of Turkish Society of Haematology (2024)
Christian Lood, Doruk Erkan
Rethinking antiphospholipid syndrome to guide future management and research. Nature reviews. Rheumatology 20 (6) (2024)
Doruk Erkan
Antiphospholipid Syndrome: To Classify or Not to Classify? Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Ayse Bahar Keleşoğlu Dinçer, Jonathan Thaler, Doruk Erkan
Persistent Moderate-to-High Levels of Isolated Anticardiolipin Antibody IgA or Anti-β 2 -Glycoprotein-I IgA Isotypes: Do They Have Any Clinical Relevance? Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (2) (2024)
Medha Barbhaiya, Stephane Zuily, Guilherme Ribeiro Ramires de Jésus, D Ware Branch, Doruk Erkan
Reply. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Doruk Erkan
Antiphospholipid Syndrome: To Classify or Not to Classify? Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Medha Barbhaiya, Stephane Zuily, Alison Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan
Reply. Arthritis & rheumatology (Hoboken, N.J.) 76 (5) (2024)
Medha Barbhaiya, Stephane Zuily, Guilherme Ribeiro Ramires de Jésus, D Ware Branch, Doruk Erkan
Reply. Arthritis & rheumatology (Hoboken, N.J.) 76 (8) (2024)
Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, Danieli Andrade, Tadej Avcin, Maria Laura Bertolaccini, D Ware Branch, Nathalie Costedoat-Chalumeau, Mark Crowther, Guilherme Ribeiro Ramires de Jésus, Katrien M J Devreese, Camille Frances, David Garcia, José A Gómez-Puerta, Francis Guillemin, Steven R Levine, Roger A Levy, Michael D Lockshin, Thomas L Ortel, Michelle A Petri, Giovanni Sanna, Savinio Sciascia, Surya V Seshan, Maria G G Tektonidou, Denis Wahl, Rohan Willis, Cecile M Yelnik, Alison Hendry, Ray Naden, Karen H Costenbader, Doruk Erkan, null null
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multi Criteria Decision Analysis. Arthritis care & research (2024)
Medha Barbhaiya, Stephane Zuily, Guilherme Ribeiro Ramires de Jésus, D Ware Branch, Doruk Erkan
Response to Correspondence on "A Diagnostic Performance Study of the 2023 ACR/EULAR Classification Criteria For Antiphospholipid Syndrome (APS) in Cohorts of Patients Presenting with Suspected APS" by Lu et al. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Christian Lood, Doruk Erkan
Rethinking antiphospholipid syndrome to guide future management and research. Nature reviews. Rheumatology 20 (6) (2024)
Medha Barbhaiya, Stephane Zuily, Alison Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan
Reply. Arthritis & rheumatology (Hoboken, N.J.) 76 (5) (2024)
Doruk Erkan
Antiphospholipid Syndrome: To Classify or Not to Classify? Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Christian Lood, Doruk Erkan
Rethinking antiphospholipid syndrome to guide future management and research. Nature reviews. Rheumatology (2024)
Medha Barbhaiya, Stephane Zuily, Alison Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan
Reply. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Doruk Erkan
Antiphospholipid Syndrome: To Classify or Not to Classify? Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Ayse Bahar Keleşoğlu Dinçer, Jonathan Thaler, Doruk Erkan
Persistent Moderate-to-High Levels of Isolated Anticardiolipin Antibody IgA or Anti-β 2 -Glycoprotein-I IgA Isotypes: Do They Have Any Clinical Relevance? Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (2) (2024)
Medha Barbhaiya, Stephane Zuily, Alison Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan
Response to "Correspondence/Comments on ACR/EULAR Antiphospholipid Syndrome Classification Criteria" by Alijotas-Reig et al. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Medha Barbhaiya, Stephane Zuily, Alison Hendry, Florian Manneville, Francis Guillemin, Karen H Costenbader, Doruk Erkan
Reply. Arthritis & rheumatology (Hoboken, N.J.) 76 (5) (2024)
Ayse Bahar Keleşoğlu Dinçer, Doruk Erkan
The ABCs of antiphospholipid syndrome. Archives of rheumatology 38 (2) (2023)
Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary-Carmen Amigo, Zahir Amoura, Danieli Andrade, Laura Andreoli, Bahar Artim-Esen, Tatsuya Atsumi, Tadej Avčin, Michael H Belmont, Maria Laura Bertolaccini, D Ware Branch, Graziela Carvalheiras, Alessandro Casini, Ricard Cervera, Hannah Cohen, Nathalie Costedoat-Chalumeau, Mark Crowther, Guilherme Ribeiro Ramires de Jésus, Aurelien Delluc, Sheetal Desai, Maria De Sancho, Katrien M Devreese, Reyhan Diz-Kucukkaya, Ali Duarte Garcia, Camille Frances, David Garcia, Jean-Christophe Gris, Natasha Jordan, Rebecca K Leaf, Nina Kello, Jason S Knight, Carl Laskin, Alfred I Lee, Kimberly Legault, Steve R Levine, Roger A Levy, Maarten Limper, Michael D Lockshin, Karoline Mayer-Pickel, Jack Musial, Pier Luigi Meroni, Giovanni Orsolini, Thomas L Ortel, Vittorio Pengo, Michelle A Petri, Guillermo J Pons-Estel, José A Gómez-Puerta, Quentin Raimboug, Robert Roubey, Giovanni Sanna, Surya V Seshan, Savinio Sciascia, Maria G G Tektonidou, Angela Tincani, Denis Wahl, Rohan Willis, Cecile M Yelnik, Catherine Zuily, Francis Guillemin, Karen H Costenbader, Doruk Erkan, null null
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary-Carmen Amigo, Zahir Amoura, Danieli Castro de Oliveira Andrade, Laura Andreoli, Bahar Artim-Esen, Tatsuya Atsumi, Tadej Avcin, H Michael Belmont, Maria Laura Bertolaccini, D Ware Branch, Graziela Carvalheiras, Alessandro Casini, Ricard Cervera, Hannah Cohen, Nathalie Costedoat-Chalumeau, Mark Crowther, Guilherme Ribeiro Ramires de Jésus, Aurelien Delluc, Sheetal Desai, Maria De Sancho, Katrien M Devreese, Reyhan Diz-Kucukkaya, Ali Duarte Garcia, Camille Frances, David Garcia, Jean-Christophe Gris, Natasha Jordan, Rebecca K Leaf, Nina Kello, Christian Lood, Carl Laskin, Alfred I Lee, Kimberly Legault, Steve R Levine, Roger Abramino Levy, Maarten Limper, Michael D Lockshin, Karoline Mayer-Pickel, Jack Musial, Pier Luigi Meroni, Giovanni Orsolini, Thomas L Ortel, Vittorio Pengo, Michelle A Petri, Guillermo J Pons-Estel, Jose A Gomez-Puerta, Quentin Raimboug, Robert Roubey, Giovanni Sanna, Surya V Seshan, Savinio Sciascia, Maria G G Tektonidou, Angela Tincani, Denis Wahl, Rohan Willis, Cécile Yelnik, Catherine Zuily, Francis Guillemin, Karen H Costenbader, Doruk Erkan, null null
2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the rheumatic diseases (2023)
Cecilia Beatrice Chighizola, Francesca Pregnolato, Danieli Andrade, Maria G G Tektonidou, Vittorio Pengo, Guillermo Ruiz-Irastorza, H Michael Belmont, Maria Gerosa, Paul R Fortin, D Ware Branch, Laura Andreoli, Michelle A Petri, Ricard Cervera, Jason S Knight, Rohan Willis, Maria Efthymiou, Hannah Cohen, Doruk Erkan, Maria Laura Bertolaccini, null null
Fluctuation of Anti-Domain 1 and Anti-Β2 Glycoprotein I Antibody Titers Over Time in Patients with Persistently Positive Antiphospholipid Antibodies. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Yu Zuo, Sherwin Navaz, Alex Tsodikov, Katarína Kmeťová, Lyndsay Kluge, Amala Ambati, Claire K Hoy, Srilakshmi Yalavarthi, Danieli de Andrade, Maria G G Tektonidou, Savinio Sciascia, Vittorio Pengo, Guillermo Ruiz-Irastorza, H Michael Belmont, Maria Gerosa, Paul R Fortin, Guilherme Ribeiro Ramires de Jésus, D Ware Branch, Laura Andreoli, Esther Rodriguez-Almaraz, Michelle A Petri, Ricard Cervera, Rohan Willis, Edward M Behrens, Quan-Zhen Li, Hannah Cohen, Maria Laura Bertolaccini, Doruk Erkan, Christian Lood, null null
Anti-NET antibodies in antiphospholipid antibody-positive patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Cecilia Beatrice Chighizola, Francesca Pregnolato, Danieli Andrade, Maria G G Tektonidou, Vittorio Pengo, Guillermo Ruiz-Irastorza, H Michael Belmont, Maria Gerosa, Paul R Fortin, D Ware Branch, Laura Andreoli, Michelle A Petri, Ricard Cervera, Jason S Knight, Rohan Willis, Maria Efthymiou, Hannah Cohen, Doruk Erkan, Maria Laura Bertolaccini, null null
Fluctuation of Anti-Domain 1 and Anti-Β2 Glycoprotein I Antibody Titers Over Time in Patients with Persistently Positive Antiphospholipid Antibodies. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Medha Barbhaiya, Stéphane Zuily, Maria Laura Bertolaccini, Rohan Willis, Katrien Devreese, Doruk Erkan
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers. Annals of the rheumatic diseases (2023)
Doruk Erkan, Medha Barbhaiya, Stéphane Zuily, Maria Laura Bertolaccini, Rohan Willis, Katrien Devreese
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al . Annals of the rheumatic diseases (2023)
Doruk Erkan
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis & rheumatology (Hoboken, N.J.) 73 (10) (2021)
Doruk Erkan, Savino Sciascia, Maria Laura Bertolaccini, Hannah Cohen, null null
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current rheumatology reports 23 (6) (2021)
Ramadan A Ali, Shanea K Estes, Alex A Gandhi, Srilakshmi Yalavarthi, Claire K Hoy, Hui Shi, Yu Zuo, Doruk Erkan, Christian Lood
Defibrotide inhibits antiphospholipid antibody-mediated NET formation and venous thrombosis. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Doruk Erkan, Savino Sciascia, Maria Laura Bertolaccini, Hannah Cohen, null null
Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current rheumatology reports 23 (7) (2021)
Maria Efthymiou, Ian J Mackie, Philip J Lane, Danieli Andrade, Rohan Willis, Doruk Erkan, Savinio Sciascia, Steven Krillis, Elisa Bison, Margarete Borges Galhardo Vendramini, Zurina Romay-Penabad, Miao Qi, Maria G G Tektonidou, Amaia Ugarte, Cecilia Chighizola, H Michael Belmont, Maria Angeles Aguirre, Lanlan Ji, D Ware Branch, Guilherme de Jesus, Paul R Fortin, Laura Andreoli, Michelle Petri, Ricard Cervera, Esther Rodriguez, Christian Lood, Tatsuya Atsumi, Joann Vega, Ecem Sevim, Maria Laura Bertolaccini, Vittorio Pengo, Hannah Cohen, null null
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. Journal of thrombosis and haemostasis : JTH 17 (12) (2019)
Stéphane Zuily, Laurent Phialy, Ecem Sevim, Eloïse Germain, Ozan Unlu, Virginie Dufrost, Jessie Risse, Isabelle Clerc-Urmes, Cédric Baumann, Jessica R Berman, Michael D Lockshin, Denis Wahl, Doruk Erkan
Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study. European journal of rheumatology 6 (4) (2019)